In vivo effect of hyperbaric oxygen on wound angiogenesis and epithelialization

Wound Repair and Regeneration

Volumn 17, Issue 2, 2009, Pages 179-184

  Sander, Anna L ^a   Henrich, Dirk ^a   Muth, Claus M ^b   Marzi, Ingo ^a   Barker, John H ^c   Frank, Johannes M ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPLETION; EPITHELIZATION; HYPERBARIC OXYGEN; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MACROPHAGE; MALE; MICROSCOPY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION; WOUND; WOUND CLOSURE; WOUND HEALING; WOUND HEALING IMPAIRMENT;

ANALYSIS OF VARIANCE; ANIMALS; CARRAGEENAN; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; EAR; GRANULATION TISSUE; HYPERBARIC OXYGENATION; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, HAIRLESS; MICROSCOPY, VIDEO; NEOVASCULARIZATION, PHYSIOLOGIC; STATISTICS, NONPARAMETRIC; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUMOR NECROSIS FACTOR-ALPHA; WOUND HEALING; WOUNDS AND INJURIES;

EID: 62449214768     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2009.00455.x     Document Type: Article

References (35)

1. Barker JH, Hammersen F, Bondar I, Uhl E, Galla TJ, Menger MD, Messmer K. The hairless mouse ear for in vivo studies of skin microcirculation. Plast Reconstr Surg 1989 83 : 948 59.
2. Barker JH, Kjolseth D, Kim M, Frank J, Bondar I, Uhl E, Kamler M, Messmer K, Tobin GR, Weiner LJ. The hairless mouse ear: an in vivo model for studying wound neovascularization. Wound Rep Reg 1994 2 : 138 43.
3. Frank JM, Kaneko S, Joels C, Tobin GR, Banis JC Jr., Barker JH. Microcirculation research, angiogenesis, and microsurgery. Microsurgery 1994 15 : 399 404.
4. Kjolseth D, Frank JM, Barker JH, Anderson GL, Rosenthal AI, Acland RD, Schuschke D, Campbell FR, Tobin GR, Weiner LJ. Comparison of the effects of commonly used wound agents on epithelialization and neovascularization. J Am Coll Surg 1994 179 : 305 12.
5. Kjolseth D, Kim MK, Andresen LH, Morsing A, Frank JM, Schuschke D, Anderson GL, Banis JC, Tobin GR, Weiner LJ, Hjortdal VE, Barker JH. Direct visualization and measurements of wound neovascularization - application in microsurgery research. Microsurgery 1994 15 : 390 8.
6. Broussard CL. Hyperbaric oxygenation and wound healing. J Vasc Nurs 2004 22 : 42 8.
7. Gill AL, Bell CNA. Hyperbaric oxygen: its uses, mechanisms of action and outcomes. Q J Med 2004 97 : 385 95.
8. Thackham JA, Sean McElwain DL, Long RJ. The use of hyperbaric oxygen therapy to treat chronic wounds: a review. Wound Rep Reg 2008 16 : 321 30.
9. Abidia A, Laden G, Kuhan G, Johnson BF, Wilkinson AR, Renwick PM, Masson EA, McCollum PT. The role of hyperbaric oxygen therapy in ischaemic diabetic lower-extremity ulcers: a double-blind randomised controlled trial. Eur J Vasc Endovasc Surg 2003 25 : 513 8.
10. Kessler L, Bilbault P, Ortéga F, Grasso C, Passemard R, Stephan D, Pinget M, Schneider F. Hyperbaric oxygenation accelerates the healing rate of nonischemic chronic diabetic foot ulcers: a prospective randomized study. Diabetes Care 2003 26 : 2378 82.
11. Boykin JV. Hyperbaric oxygen therapy: a physiological approach to selected problem wound healing. Wounds 1996 8 : 183 98.
12. Zhang Q, Chang Q, Cox RA, Gong X, Gould LJ. Hyperbaric oxygen attenuates apoptosis and decreases inflammation in an ischemic wound model. J Invest Dermatol 2008 128 : 2102 12.
13. Knighton DR, Silver IA, Hunt TK. Regulation of wound-healing angiogenesis - effect of oxygen gradients and inspired oxygen concentration. Surgery 1981 90 : 262 70.
14. Lahat N, Bitterman H, Yaniv N, Kinarty A, Bitterman N. Exposure to hyperbaric oxygen induces tumour necrosis factor-alpha (TNF-alpha) secretion from rat macrophages. Clin Exp Immunol 1995 102 : 655 9.
15. Frank JM, Born K, Barker JH, Marzi I. In vivo effect of tumor necrosis factor alpha on wound angiogenesis and epithelialization. Eur J Trauma 2003 29 : 1 13.
16. Frater-Schroder M, Risau W, Hallmann R, Gautschi P, Bohlen P. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci USA 1987 84 : 5277 81.
17. Mauviel A, Daireaux M, Redini F, Galera P, Loyau G, Pujol JP. Tumor necrosis factor inhibits collagen and fibronectin synthesis in human dermal fibroblasts. FEBS Lett 1988 236 : 47 52.
18. Regan MC, Kirk SJ, Hurson M, Sodeyama M, Wasserkrug HL, Barbul A. Tumor necrosis factor-alpha inhibits in vivo collagen synthesis. Surgery 1993 113 : 173 7.
19. Mooney DP, O'Reilly M, Gamelli RL. Tumor necrosis factor and wound healing. Ann Surg 1990 211 : 124 9.
20. Piguet PF, Grau GE, Vassalli P. Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis. Am J Pathol 1990 136 : 103 10.
21. Roesel JF, Nanney LB. Assessment of differential cytokine effects on angiogenesis using an in vivo model of cutaneous wound repair. J Surg Res 1995 58 : 449 59.
22. Appleton I, Tomlinson A, Colvillenash PR, Willoughby DA. Temporal and spatial immunolocalization of cytokines in murine chronic granulomatous tissue. Implications for their role in tissue-development and repair processes. Lab Invest 1993 69 : 405 14.
23. 3 in a new chronic wound model in aged rabbits. Arch Surg 2000 135 : 1148 53.
24. Leibovich SJ, Wiseman DM. Macrophages, wound repair and angiogenesis. Prog Clin Biol Res 1988 266 : 131 45.
25. Uhl E, Sirsjo A, Haapaniemi T, Nilsson G, Nylander G. Hyperbaric-oxygen improves wound-healing in normal and ischemic skin tissue. Plast Reconstr Surg 1994 93 : 835 41.
26. Parks WC. Matrix metalloproteinases in repair. Wound Rep Reg 1999 7 : 423 32.
27. Rahat MA, Marom B, Bitterman H, Weiss-Cerem L, Kinarty A, Lahat N. Hypoxia reduces the output of matrix metalloproteinase-9 (MMP-9) in monocytes by inhibiting its secretion and elevating membranal association. J Leukoc Biol 2006 79 : 706 18.
28. Moon SK, Cha BY, Kim CH. ERK1/2 mediates TNFα-induced matrix metalloproteinases-9 expression in human vascular smooth muscle cells via regulation of NFκB and AP-1: involvement of the ras dependent pathway. J Cell Physiol 2004 198 : 417 27.
29. Han Y, Tuan T, Wu H, Hughes M, Garner WL. TNF-α stimulates activation of pro-MMP2 in human skin through NF-κB mediated induction of MT1-MMP. J Cell Sci 2000 114 : 131 9.
30. Madlener M. Differential expression of matrix metalloproteinases and their physiological inhibitors in acute murine skin wounds. Arch Dermatol Res 1998 290 (Suppl.) : S24 9.
31. Moses MA, Marikovsky M, Harper JW, Vogt P, Eriksson E, Klagsbrun M, Langer R. Temporal study of the activity of matrix metalloproteinases and their endogenous inhibitors during wound healing. J Cell Biochem 1996 60 : 379 86.
32. Boykin JV Jr., Baylis C. Hyperbaric oxygen therapy mediates increased nitric oxide production associated with wound healing: a preliminary study. Adv Skin Wound Care 2007 20 : 382 8.
33. Bauer JA, Rao W, Smith DJ. Evaluation of linear polyethyleneimine/nitric oxide adduct on wound repair: therapy versus toxicity. Wound Rep Reg 1998 6 : 569 77.
34. Bove PF, Wesley UV, Greul A, Hristova M, Dostmann WR, van der Vliet A. Nitric oxide promotes airway epithelial wound repair through enhanced activation of MMP-9. Am J Respir Cell Mol Biol 2006 36 : 138 46.
35. Schäffer M, Bongartz M, Hoffmann W, Viebahn R. Regulation of nitric oxide synthesis in wounds by INF-γ depends on TNF-α. J Invest Surg 2006 19 : 371 9.